Anticoagulation and Antiplatelet Discontinuation Prior to Surgery

WHS Monoclonal Antibody Therapeutics for COVID-19

WHS follows current HHS guidelines and antibody availability when administering monoclonal antibody therapy to COVID-19 positive patients in the outpatient setting.  When a provider has deemed a patient an appropriate candidate and a request form has been submitted through the appropriate review process, an approved patient will receive either:

Antibody Name Dosing EUA Reference
Bebtelovimab 175 mg click here -> fda.gov/media/156153/download